Perspective Therapeutics, Inc. — Director's Dealing 2023

Dec 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2023-12-12

Reporting Person: HENSON HEIDI (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-12	Stock Options (right to buy)	$0.24	A	230000	Acquired	2033-12-12	Common Stock (230000)	Direct

Footnotes

F1: 100% vests 12/12/2024.